Shenzhen Salubris Pharmaceuticals Co. Ltd. | Ownership
Companies that own Shenzhen Salubris Pharmaceuticals Co. Ltd.
Da Cheng Fund Management Co., Ltd.
36,852,050
3.52%
21,236,857
3.48%
06/30/2017
China Investment Corp. (Investment Management)
14,370,900
1.37%
0
0.18%
06/30/2017
Zhong Ou Asset Management Co., Ltd
6,181,546
0.59%
3,533,212
0.5%
12/31/2017
Harvest Fund Management Co., Ltd.
5,951,900
0.56%
0
0.18%
06/30/2017
Yinhua Fund Management Co., Ltd.
5,932,600
0.56%
-16,900
0.42%
06/30/2017
China Asset Management Co., Ltd.
5,775,417
0.55%
-175,523
0.13%
06/30/2017
GF Fund Management Co., Ltd.
5,740,100
0.55%
-95,400
0.31%
06/30/2017
Changsheng Fund Management Co., Ltd.
5,614,790
0.54%
2,859,110
1.34%
12/31/2017
Rongtong Fund Management Co., Ltd.
2,400,347
0.23%
264,780
0.38%
12/31/2017
Lion Fund Management Co., Ltd.
2,144,382
0.21%
725,219
0.46%
12/31/2017
| Address |
37/F, Chegongmiao Lujing Plaza Bldg
Shenzhen Guangdong 518040
China
|
|
Employees
|
- |
| Website |
http://www.salubris.cn |
| Updated |
07/08/2019 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and biomedical products. It offers cardiovascular drugs and antibiotics, and active pharmaceutical ingredient products. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China. |
